Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones

It is well accepted that the immune system efficiently contributes to positive outcomes of chemotherapeutic cancer treatment by activating immunogenic cell death (ICD). However, only a limited number of ICD-in...

Source: Journal of Inflammation - June 10, 2021 Category: Allergy & Immunology Authors: Fangtian Fan, Peiliang Shen, Yue Ma, Wangbo Ma, Hongyan Wu, Hao Liu and Qing An Tags: Research Source Type: research